Patent · US Expired

Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity

US6794396B2 · kind B2 · utility

7Cited by

21References

14Claims

0Family size

Assignee

Pharmacia Corporation · SE

Inventors

Len F. Lee · Holden, US
Kevin C. Glenn · Maryland Heights, US
Daniel T. Connolly · Ballwin, US
David Corley · Chesterfield, US
Daniel L. Flynn · Lawrence, US
Ashton T. Hamme · Chesterfield, US
Shridhar Hegde · Beaverton, US
Michele A. Melton · Bridgeton, US
Roger Schilling · Chesterfield, US
James A. Sikorski · Des Peres, US
Nancy N. Wall · Florissant, US
Jeffery A. Zablocki · Skokie, US

Key dates

Filing date	Mar 31, 2003
Grant date	Sep 21, 2004
Priority date	—
Expiry date	Mar 31, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A class of substituted pyridines that are useful for inhibiting the activity of cholesteryl ester transfer protein, and have the structural formula (IA), wherein R2, R3, R4, R5, and R6 are defined in the claims.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.